Lithium-Sensitive Store-Operated Ca2+ Entry in the Regulation of FGF23 Release.

Bingbing Zhang,Jing Yan,Sebastian Schmidt,Madhuri S. Salker,Dorothea Alexander,Michael Föller,Florian Lang

Lithium-Sensitive Store-Operated Ca2+ Entry in the Regulation of FGF23 Release.

2015

Bingbing Zhang
Jing Yan
Sebastian Schmidt
Madhuri S. Salker
Dorothea Alexander
Michael Föller
Florian Lang

Background/Aims: Lithium, a widely used drug for the treatment of mood disorders, has previously been shown to stimulate the release of fibroblast growth factor F

Keywords:

Biochemistry
Drug
Mood disorders
Pharmacology
Internal medicine
Endocrinology
Lithium
Thapsigargin
ORAI1
STIM1
Biology
Fibroblast growth factor
ca2 entry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

117

References

Citations